MedTrace Logo

Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence

NCT00333073 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2014-02-17

No results posted yet for this study

Summary

To assess effectiveness of Bulkamid® injection in females suffering from stress or mixed (stress and urge) urinary incontinence after 12 months follow up period

Conditions

Interventions

DEVICE

Bulkamid

initial injection with option for second (if required)

Sponsors & Collaborators

  • Contura

    lead INDUSTRY

Principal Investigators

  • Gunnar Lose, Prof., MD · KAS Glostrup

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2008-10-31
Completion
2010-05-31

Countries

  • Denmark
  • Finland
  • Germany
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00333073 on ClinicalTrials.gov